ARCUTIS BIOTHERAPEUTICS INC
ARQTNASDAQ🏆 #1434 by market capEarnings Nov 4 · PostUS Equity
$31.97▲ $0.52 (+1.65%)
🌙 After hours$31.97▲ 0.00%Regular close · extended-hours price shownTrack ARQT
Get earnings, price moves & breaking news on Telegram
24h▲ 1.6%
7d▼ 0.7%
14d▲ 9.9%
30d▲ 19.6%
ytd▲ 10.1%
1y▲ 26.5%
🏦Market Cap
$4.02B
Small Cap
📈Revenue Growth (YoY)
76.1%
High Growth
📊Gross Margin
91.1%
High
💵FCF Margin
—
⚖️P/S Ratio
8.6x
Elevated
Otter Score
76
Strong
ARCUTIS BIOTHERAPEUTICS INC
ARQTAnalyst Ratings
Price
$31.97
Total
12
Raised
0
Lowered
1
Avg PT
$42.25
H / L
$48 / $38
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Guggenheim | Reiterated | Buy | 2026-10-19 | $44.00 | +37.60% |
Needham | Reiterated | Buy | 2026-08-06 | $18.00 | −43.70% |
Morgan Stanley | Reiterated | Overweight | 2026-08-06 | $38.00 | +18.90% |
Mizuho | Reiterated | Outperform | 2026-03-02 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2026-02-26 | — | — |
TD Cowen | Reiterated | Buy | 2026-02-26 | — | — |
Goldman Sachs | Reiterated | Neutral | 2025-10-30 | $29.00 | −9.30% |
Jefferies | Reiterated | Buy | 2025-03-11 | $39.00 | +22.00% |
JonesTrading | Downgraded | Buy → Hold | 2023-11-08 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2023-08-22 | $48.00 | +50.10% |
Truist Securities | Reiterated | Buy | 2023-05-26 | — | — |
Cowen & Co. | Reiterated | Outperform | 2021-02-01 | — | — |
Institution
Guggenheim
Reiterated · Buy · 2026-10-19
$44.00
+37.60%
Needham
Reiterated · Buy · 2026-08-06
$18.00
−43.70%
Morgan Stanley
Reiterated · Overweight · 2026-08-06
$38.00
+18.90%
Mizuho
Reiterated · Outperform · 2026-03-02
—
—
HC Wainwright & Co.
Reiterated · Buy · 2026-02-26
—
—
TD Cowen
Reiterated · Buy · 2026-02-26
—
—
Goldman Sachs
Reiterated · Neutral · 2025-10-30
$29.00
−9.30%
Jefferies
Reiterated · Buy · 2025-03-11
$39.00
+22.00%
JonesTrading
Downgraded · Buy → Hold · 2023-11-08
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2023-08-22
$48.00
+50.10%
Truist Securities
Reiterated · Buy · 2023-05-26
—
—
Cowen & Co.
Reiterated · Outperform · 2021-02-01
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space